Octave develops blood-based biomarker tests that illuminate the path forward for patients with neurodegenerative diseases, starting with multiple sclerosis
Octave develops blood-based biomarker tests that illuminate the path forward for patients with neurodegenerative diseases, starting with multiple sclerosis. Their MSDA Test provides a quantitative score to support clinical decision-making.